Presentation Information
[F1-45]Development of a PEG Substitute Lipid for LNP Formulations to Reduce Immunogenic Risk Associated with Anti-PEG Antibodies
*Hirano Ayaka1, Matsumoto Makoto1, Mukai Hidefumi1, Kawakami Shigeru1 (1. Nagasaki University (Japan))
Password required to view
Log in
or
Comment
To browse or post comments, you must log in.Log in
